Precision Nanomedicine for Renal Tubular Injury: From Passive Accumulation to Subcellular Targeting
International Journal of Nanomedicine · 2026-07 · Volume 21 · 1-22
DOI: 10.2147/ijn.s616742 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026-07. Verfasst von Yaotong Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China. Hauptthemen laut MEDLINE: Nanomedicine, Kidney Tubules, Precision Medicine, Kidney Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Renal tubular epithelial cell injury is a central pathogenic feature of kidney diseases, yet precise therapeutic interventions remain elusive. Conventional nanomedicines relying on passive accumulation lack the specificity required to treat complex tubular pathologies. This review elucidates the evolution of renal nanotherapeutics from non-specific organ accumulation to active, biologically informed targeting. We examine strategies utilizing specific surface receptors and injury-associated microenvironmental signals to engineer ligand-directed and stimuli-responsive nanocarriers. Furthermore, we highlight biomimetic platforms, such as engineered extracellular vesicles. Crucially, to achieve the ultimate goal of precision intervention, we emphasize the necessity of subcellular targeting. With a primary focus on mitochondria, we delineate hierarchical delivery strategies designed to restore cellular bioenergetics and metabolic homeostasis. Finally, we provide a forward-looking perspective on overcoming translational barriers by integrating DNA barcoding and artificial intelligence to accelerate the discovery of clinically translatable, precision nanomedicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nephrology Department, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China.
- Nephrology Department, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu, People's Republic of China.
ORCID-Profile: Yaotong Shi
Zitieren
APA
Shi, Y., Lu, Y., Zhou, Y., Chen, R., Li, Z., Liu, H., & Cao, J. (2026). Precision Nanomedicine for Renal Tubular Injury: From Passive Accumulation to Subcellular Targeting. International Journal of Nanomedicine, Volume 21, 1-22. https://doi.org/10.2147/ijn.s616742
Vancouver
Shi Y, Lu Y, Zhou Y, Chen R, Li Z, Liu H, et al. Precision Nanomedicine for Renal Tubular Injury: From Passive Accumulation to Subcellular Targeting. International Journal of Nanomedicine. 2026;Volume 21:1-22. doi:10.2147/ijn.s616742
BibTeX
@article{Shi2026,
author = {Shi, Yaotong and Lu, Yuan and Zhou, Yan and Chen, Ruoxin and Li, Zuolin and Liu, Hong and Cao, Jingyuan},
title = {Precision Nanomedicine for Renal Tubular Injury: From Passive Accumulation to Subcellular Targeting},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--22},
doi = {10.2147/ijn.s616742}
}
EUVIMED